Search results with tag "Coronavac"

Evidence Assessment: Sinovac/CoronaVacCOVID-19 vaccine

Apr 05, 2021 · Key evidence to inform policy recommendations on the use of CoronaVac Background • 2-dose β-propiolactone-inactivated, aluminiumhydroxide-adjuvanted COVID-19 vaccine administered on a 0/14-28-day schedule for the prevention of COVID-19 disease • Authorized by the China National Medical Products Administration on February 6, 2021

  Recommendations, Coronavac